Showing 1 - 5 results of 5 for search 'Hye-Min Woo', query time: 0.03s Refine Results
  1. 1
    Isolation of single-stranded DNA aptamers that distinguish influenza virus hemagglutinin subtype H1 from H5.

    Isolation of single-stranded DNA aptamers that distinguish influenza virus hemagglutinin subtype H1 from H5. by Hye-Min Woo, Jin-Moo Lee, Sanggyu Yim, Yong-Joo Jeong

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning

    Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning by Yoonji Kim, Hansaem Lee, Keunwan Park, Sora Park, Ju-Hyeon Lim, Min Kyung So, Hye-Min Woo, Hyemin Ko, Jeong-Min Lee, Sun Hee Lim, Byoung Joon Ko, Yeon-Su Park, So-Young Choi, Du Hyun Song, Joo-Yeon Lee, Sung Soon Kim, Dae Young Kim

    Published 2019-07-01
    Get full text
    Article
  3. 3
    Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.

    Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus. by Jang-Hoon Choi, Hye-Min Woo, Tae-Young Lee, So-Young Lee, Sang-Mu Shim, Woo-Jung Park, Jeong-Sun Yang, Joo Ae Kim, Mi-Ran Yun, Dae-Won Kim, Sung Soon Kim, Yi Zhang, Wei Shi, Lingshu Wang, Barney S Graham, John R Mascola, Nanshuang Wang, Jason S McLellan, Joo-Yeon Lee, Hansaem Lee

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Ji-Min Seo, Bobin Kang, Rina Song, Hanmi Noh, Cheolmin Kim, Jong-In Kim, Minsoo Kim, Dong-Kyun Ryu, Min-Ho Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Hansaem Lee, Hye-Min Woo, Jun-Won Kim, Jung-Ah Choi, Manki Song, Monika Tomaszewska-Kiecana, Anna Wołowik, Agnieszka Kulesza, Sunghyun Kim, Keumyoung Ahn, Nahyun Jung, Soo-Young Lee

    Published 2022-12-01
    Get full text
    Article
  5. 5
    A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

    A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein by Cheolmin Kim, Dong-Kyun Ryu, Jihun Lee, Young-Il Kim, Ji-Min Seo, Yeon-Gil Kim, Jae-Hee Jeong, Minsoo Kim, Jong-In Kim, Pankyeom Kim, Jin Soo Bae, Eun Yeong Shim, Min Seob Lee, Man Su Kim, Hanmi Noh, Geun-Soo Park, Jae Sang Park, Dain Son, Yongjin An, Jeong No Lee, Ki-Sung Kwon, Joo-Yeon Lee, Hansaem Lee, Jeong-Sun Yang, Kyung-Chang Kim, Sung Soon Kim, Hye-Min Woo, Jun-Won Kim, Man-Seong Park, Kwang-Min Yu, Se-Mi Kim, Eun-Ha Kim, Su-Jin Park, Seong Tae Jeong, Chi Ho Yu, Youngjo Song, Se Hun Gu, Hanseul Oh, Bon-Sang Koo, Jung Joo Hong, Choong-Min Ryu, Wan Beom Park, Myoung-don Oh, Young Ki Choi, Soo-Young Lee

    Published 2021-01-01
    Get full text
    Article

Search Tools: